Vietnam Succeeds in Producing H5N1 Bird Flu Vaccine in Laboratory
Posted on: Saturday, 18 February 2006, 06:00 CST
Text of report in English by Vietnamese news agency VNA website
Khanh Hoa, 17 February: The Nha Trang Institute of Vaccine (IVAC) in central Khanh Hoa province has succeeded in developing a vaccine against bird flu virus strain H5N1 on chicken embryos in its laboratory.
Dr Le Van Hiep, IVAC Director, said his institute used the reassortant influenza strain NIBRG-14 provided by the British National Institute for Biological Standard and Control.
The first two lots of 200 doses of the H5N1 vaccine are being tested on rabbits and mice and will show final results later this month.
The IVAC plans to produce an additional 2,000 doses of the H5N1 vaccine for testing on humans within 18 months.
If the results are effective, mass production of the vaccine will begin in mid-2007.
The IVAC will be able to provide about 4m doses of the vaccine at 20,000 dong per dose, much cheaper than imported vaccines.
Source: BBC Monitoring Asia Pacific
Related Articles
- "Single-Shot" Vaccines Could Protect Against H5N1 Influenza Virus
- Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier
- Novartis Opens New Vaccine Research Institute
- Sanofi-Aventis Says Flu Vaccine Protects Against New H5N1 Strains
- Vaccine's Promise Grows: Doses Might Protect Against Head, Neck Tumors, Study Says
- Volunteers Sought for Testing HIV Vaccine: UM Institute to Take Part in Research on GeoVax Product
- Bird Flu Oral Vaccine Licensed By MDM Group
- New Vaccines Necessary for New Bird Flu Strain: U.S. Official
- H5N1 Avian Influenza: First Steps Towards Development of a Human Vaccine/Grippe Aviaire Virus H5N1 - Les Premiers Pas Dans Le Dveloppement D'UN Vaccin Pour L'Homme
 |
 |
User Comments (0)
RSS Feeds